Global Clinical Nutrition Market

Global Clinical Nutrition Market Overview:

Clinical nutrition is a broad subject that uses food characteristics and adjusts body metabolism under pathological conditions to relieve symptoms, promote rehabilitation, and improve the quality of life after healing. The dietary nutrition measures taken based on the principles of nutrition are called therapeutic diets, which are divided into therapeutic diets and experimental diets according to their functions. Clinical nutrition is the prevention and treatment of nutritional deficiencies. Clinical nutrition should include enteral nutrition (nutrition meals, patient diet management), parenteral nutrition (intravenous nutrition), and nutrition clinic.

Global Clinical Nutrition Market Insights

The global clinical nutrition market size was valued around USD 56.03 Billion in 2019 and projected to generate USD 100.88 Billion by 2027, registering a CAGR of 7.29%, during the forecast period, 2020-2027. The growth of the market can be attributed to the rise in the number of people suffering from chronic diseases such as cancer and diabetes, along with the growing geriatric population base. Further, the ever-increasing geriatric and aging population, mostly in the developed economies, will spur the growth of the market. Additionally, the surge in the prevalence of metabolic disorders, high spending on healthcare, and the augmentation of the middle class are anticipated to boost the global clinical nutrition market share. Also, the higher birth rate, the increasing number of malnutrition victims receiving treatment, and a higher number of premature births expected to foster the growth of the market. Moreover, the growing obese population as a result of unhealthy dietary habits and physical inactivity will drive the clinical nutrition industry. Furthermore, the improved healthcare system, coupled with the high rate of birth in developing nations, will fuel the growth of the global clinical nutrition industry. Also, the rising prevalence of metabolic diseases and increases healthcare spending across emerging nations are strengthening market growth. The upsurge in the prevalence of chronic disorders and the rise in the number of patients using the advanced clinical nutritional product will impact the growth of the global clinical nutrition market in the upcoming periods. Additionally, the growing usage of clinical nutrition to provide a sufficient amount of nutrients such as vitamins, protein, and minerals to the patients and helps to keep energy balance is positively impacting the demand.

Growth Driver

Increasing metabolic disorders across the world

Metabolic disorders are directly related to cardiovascular diseases such as congenital heart disease, macrovascular disease, arrhythmia, heart failure, and ischemic heart disease. Glucose metabolism disorder, lipid metabolism disorder, and amino acid metabolism disorder will all aggravate cardiovascular disease death. The metabolism is regulated by genetics, neurohumor, hormones, enzymes, liver, and other tissues and organs. When these factors are abnormal, it can cause lipid metabolism disorders and pathophysiological changes associated with organs, such as hyperlipoproteinemia, lipid storage diseases resulting in clinical syndrome, obesity, ketosis acidosis, fatty liver, and neonatal scleroderma.

The increasing geriatric population worldwide

According to the United Nations, the world’s population will reach 11 billion by the end of this century, and 2 billion people will be added in the next 30 years. Further, the global population would increase by 2 billion people in the next 30 years, from 7.7 billion in 2019 to 9.7 billion in 2050. By the end of this century, the global population will continue to grow to about 11 billion.

Growing rate of premature birth & birth rate worldwide

According to WHO, every year, an estimated 15 million babies are born preterm, and approximately 1 million children die each year due to complications of preterm birth. These factors will enhance the demand for clinical nutrition in developing nations and under developing countries to survive the life of the newborn baby.

Impact of Covid19

Recently outbreak pandemic, COVID-19, a disease caused by a novel coronavirus that mainly targets the human respiratory system. In this situation, proper nutrition and hydration are vital. WHO advised eating a variety of fresh and unprocessed foods every day to get the vitamins, minerals, dietary fiber, protein, and antioxidants body needs. These respiratory diseases are mainly affecting the old age population and newborn baby. These factors will influence the global clinical nutrition market.

Product Segmental Analysis

Based on the product, the global clinical nutrition market classified into Infant Nutrition (Milk, Soy, and Organic), Parenteral Nutrition (Amino Acids, Fats, and Carbohydrates), Enteral Nutrition (Standard Composition, Disease-Specific Composition). The infant nutrition dominated the global market in 2019 and is projected to expand with a higher CAGR through the forecast period. It is primarily attributed to the surge in the number of premature births and malnourished babies, along with increasing awareness camps by domestic governments about infant nutritional products. Parenteral Nutrition will grow with a significant rate in the estimated period due to the surge in the number of people who have cancer, ischemic bowel disease, and Crohn’s disease for which they require an external supply of nutrients.

Application Segmental Analysis

Based on the application, the global clinical nutrition market segregated into cancer, neurological disease, gastrointestinal disorders, metabolic disorders, and others. The cancer segment held a lucrative share in 2019 and likely to dominate the global clinical nutrition market by 2027. It is due to the rise in the number of cancer affected patients along with nutritional deficiency that arises in patients as of various cancer treatments such as chemotherapy, hormone therapy, etc. The metabolic disorders will grow at a substantial CAGR in the forecast period. It is owing to the rise in the number of heart disease patients and blood pressure patients around the world.

End-User Segmental Analysis

Based on end-user, the global clinical nutrition market segmented into a pediatric, adult, and geriatric. The pediatric segment estimated to lead the market by 2027 due to the increasing number of preterm births coupled with growing awareness about clinical nutritional products. The adult segment will grow with a significant rate during the forecast period owing to the growing patient population suffering from chronic conditions, and the surge in consumption of junk food leads to scarcity of essential nutrients by this age group.

Region Segmental Analysis

Based on geography, the global clinical nutrition market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominated the industry in 2019 and will capture the highest CAGR by 2027. It is owing to a hectic lifestyle and unhealthy dietary habits leading to a large number of people suffering from chronic diseases such as obesity and diabetes. The Asia Pacific will be the fastest-growing segment during the forecast span due to the rise in metabolic disorders, high disposable incomes, and improvement in growing among patients regarding the benefits of clinical nutrition products.

Competitor Analysis

Companies such as Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Danone, Fresenius Kabi, Hospira, Mead Johnson, Perrigo, Nestle Nutrition, Ajinomoto Co. Inc, Lonza Ltd, Gentiva Health Services Inc., Kendall, Hero Nutritionals Inc., American Home Patient Inc., H. J. Heinz Company are the key players in the global clinical nutrition market.

Key Stakeholders

• Market research and consulting firms
• Industry associations
• Global Clinical Nutrition manufacturing firm
• Research organizations and consulting companies
• Organizations, associations, and alliances related to clinical nutrition
• Regulatory bodies
• Suppliers
• Retailers

The objective of the Research

• Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
• Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
• Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
• Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
• The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.

Market Modelling

By Product

• Infant Nutrition
• Parenteral Nutrition
• Enteral Nutrition

By Application

• Cancer
• Neurological disease
• Gastrointestinal Disorders
• Metabolic disorders
• Others

By End-User

• Pediatric
• Adult
• Geriatric

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

India IV Cannula Market

Global Beta Glucan Market

Global Hospital Capacity Management Solutions Market

Wearable Healthcare Devices Market

Online Streaming Services Market

Oncology Informatics Market

Global Oligonucleotide Synthesis Market

Satellite Communication for IoT Network Market

Procure to Pay Solutions Market